Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

HLA-A2 restricted CD8 T-cell line expressing MART-1 T-cell receptor

EU orphan designation number: EU/3/04/202   
Active ingredient: HLA-A2 restricted CD8 T-cell line expressing MART-1 T-cell receptor
Indication: Treatment of MART-1 positive malignant melanoma in HLA-A2 positive patients
Sponsor: Cellcure A/S
Østjysk Innovation A/S, Gustav Wieds Vej 10, DK-8000, Aarhus C, Danmark

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
24/06/2004 Centralised Orphan - Designation EMEA/OD/009/04 (2004)6311 of 21/06/2004
17/10/2006 Other procedure